Published in Psychiatr Serv on September 01, 2007
Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials. Schizophr Bull (2012) 2.30
The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr Bull (2007) 1.72
Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives. Psychiatr Serv (2010) 1.64
Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes (2010) 1.60
Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med (2015) 1.45
Psychotropic medication nonadherence among United States Latinos: a comprehensive literature review. Psychiatr Serv (2009) 1.44
The reality of dietary compliance in the management of phenylketonuria. J Inherit Metab Dis (2010) 1.37
Predictors of medication adherence using a multidimensional adherence model in patients with heart failure. J Card Fail (2008) 1.37
Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Prim Care Companion J Clin Psychiatry (2009) 1.33
Effects of eHealth interventions on medication adherence: a systematic review of the literature. J Med Internet Res (2011) 1.27
Improving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: a randomised controlled trial to evaluate the effect of monitoring patients' medication use combined with short message service (SMS) reminders. BMC Health Serv Res (2011) 1.23
A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with Schizophrenia. Psychiatry (Edgmont) (2010) 1.18
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Meas (2014) 1.17
Medication Adherence Measures: An Overview. Biomed Res Int (2015) 1.16
Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry (2013) 1.12
Measurement of psychiatric treatment adherence. J Psychosom Res (2009) 1.12
What are validated self-report adherence scales really measuring?: a systematic review. Br J Clin Pharmacol (2014) 1.11
Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment. BMC Womens Health (2010) 1.03
Barriers to, and strategies for, starting a long acting injection clinic in a community mental health center. Community Ment Health J (2011) 1.01
Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia. Patient Prefer Adherence (2013) 1.01
Risperidone long-acting injection: a review of its long term safety and efficacy. Neuropsychiatr Dis Treat (2008) 0.98
Impact of pharmacist interventions on patients' adherence to antidepressants and patient-reported outcomes: a systematic review. Patient Prefer Adherence (2012) 0.96
Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa. Patient Prefer Adherence (2013) 0.87
A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine. J Child Adolesc Psychopharmacol (2010) 0.87
Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians' perceptions of adherence vs. pharmacy claims. Int J Clin Pract (2012) 0.87
A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol (2016) 0.87
Factors related to high and low levels of drug adherence according to patients with type 2 diabetes. Int J Clin Pharm (2011) 0.86
Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia. Patient Prefer Adherence (2013) 0.86
A comparison of adherence to hypoglycemic medications between Type 2 diabetes patients with and without serious mental illness. Psychiatry Res (2011) 0.85
Accuracy of measures of medication adherence in a cholesterol-lowering regimen. West J Nurs Res (2012) 0.84
Denial and acceptance coping styles and medication adherence in schizophrenia. J Nerv Ment Dis (2009) 0.83
Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder. J Clin Psychiatry (2013) 0.82
Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study. BMC Psychiatry (2015) 0.82
Tackling nonadherence in psychiatric disorders: current opinion. Neuropsychiatr Dis Treat (2014) 0.81
Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies. Eur Neuropsychopharmacol (2015) 0.81
Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial. BMC Psychiatry (2013) 0.80
Risk factors for drug nonadherence in antidepressant-treated patients and implications of pharmacist adherence instructions for adherence improvement. Patient Prefer Adherence (2012) 0.78
Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study. Int J Bipolar Disord (2014) 0.78
The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use. J Dual Diagn (2012) 0.77
Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms. J Psychopharmacol (2015) 0.77
A New Psychosocial Tool for Gaining Patient Understanding and Acceptance of Long-acting Injectable Antipsychotic Therapy. Psychiatry (Edgmont) (2009) 0.77
Impact of depression and social support on nonadherence to antipsychotic drugs in persons with schizophrenia in Thailand. Patient Prefer Adherence (2010) 0.77
Comparison of treatment adherence between selective serotonin reuptake inhibitors and moclobemide in patients with social anxiety disorder. Psychiatry Investig (2012) 0.76
The Daily Activity Report (DAR) a Novel Measure of Functional Outcome for Serious Mental Illness. Schizophr Bull (2015) 0.76
Effect of a Multi-Dimensional and Inter-Sectoral Intervention on the Adherence of Psychiatric Patients. PLoS One (2015) 0.76
Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection. Patient Prefer Adherence (2009) 0.75
Issues and developments related to assessing function in serious mental illness. Dialogues Clin Neurosci (2016) 0.75
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life. Neuropsychiatr Dis Treat (2016) 0.75
Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials. BJPsych Open (2016) 0.75
Comparing medication attitudes and reasons for medication nonadherence among three disparate groups of individuals with serious mental illness. J Nerv Ment Dis (2014) 0.75
Nurses' perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey. Ther Adv Psychopharmacol (2015) 0.75
Quantitative levels of aripiprazole parent drug and metabolites in urine. Psychopharmacology (Berl) (2014) 0.75
Evidence review and clinical guidance for the use of ziprasidone in Canada. Ann Gen Psychiatry (2013) 0.75
Effect of a system-oriented intervention on compliance problems in schizophrenia: a pragmatic controlled trial. Schizophr Res Treatment (2014) 0.75
Patient Compliance during 24-Hour Dual pH Probe Monitoring for Extraesophageal Reflux. ISRN Otolaryngol (2011) 0.75
Development and application of an aggregate adherence metric derived from population pharmacokinetics to inform clinical trial enrichment. J Pharmacokinet Pharmacodyn (2015) 0.75
Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics. Int J Neuropsychopharmacol (2014) 0.75
[Risk factors for treatment adherence in patients with schizophrenia: case-control study]. Pan Afr Med J (2015) 0.75
Psychotropic medication in geriatric psychiatric patients: use and unreported use in relation to serum concentrations. Eur J Clin Pharmacol (2014) 0.75
The genome sequence of the malaria mosquito Anopheles gambiae. Science (2002) 20.36
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Correspondence of the brain's functional architecture during activation and rest. Proc Natl Acad Sci U S A (2009) 16.93
A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science (2002) 9.59
Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature (2002) 8.28
Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol (2006) 8.05
Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med (2013) 7.52
The ecoresponsive genome of Daphnia pulex. Science (2011) 6.55
Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry (2004) 6.40
Mammalian heart renewal by pre-existing cardiomyocytes. Nature (2012) 5.56
MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A (2007) 4.92
ALE meta-analysis: controlling the false discovery rate and performing statistical contrasts. Hum Brain Mapp (2005) 4.25
Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry (2009) 4.22
TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol (2009) 4.05
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage (2009) 3.66
Physical health monitoring of patients with schizophrenia. Am J Psychiatry (2004) 3.54
The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry (2008) 3.29
Investigating the functional heterogeneity of the default mode network using coordinate-based meta-analytic modeling. J Neurosci (2009) 3.21
Behavioral interpretations of intrinsic connectivity networks. J Cogn Neurosci (2011) 3.09
Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg (2003) 2.88
Sleep and neurobehavioral characteristics of 5- to 7-year-old children with parentally reported symptoms of attention-deficit/hyperactivity disorder. Pediatrics (2003) 2.69
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study. Am J Psychiatry (2007) 2.68
Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions. Cogn Affect Behav Neurosci (2012) 2.57
Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia. Nature (2012) 2.52
LAZY1 controls rice shoot gravitropism through regulating polar auxin transport. Cell Res (2007) 2.43
Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis (2005) 2.40
Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci U S A (2008) 2.33
Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biol Psychiatry (2012) 2.33
A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. Kidney Int (2011) 2.30
Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry (2007) 2.27
Metaanalytic connectivity modeling: delineating the functional connectivity of the human amygdala. Hum Brain Mapp (2010) 2.27
Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis. Hypertension (2010) 2.12
Isothermal strand-displacement amplification applications for high-throughput genomics. Genomics (2002) 1.99
Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor. J Neurosci (2011) 1.96
Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr (2008) 1.95
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC). Bipolar Disord (2010) 1.90
Cycles of chromosome instability are associated with a fragile site and are increased by defects in DNA replication and checkpoint controls in yeast. Genes Dev (2005) 1.89
Neuroimaging of inhibitory control areas in children with attention deficit hyperactivity disorder who were treatment naive or in long-term treatment. Am J Psychiatry (2006) 1.88
Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr (2013) 1.87
Conceptualizing impulsivity and risk taking in bipolar disorder: importance of history of alcohol abuse. Bipolar Disord (2009) 1.82
Comparison of the disparity between Talairach and MNI coordinates in functional neuroimaging data: validation of the Lancaster transform. Neuroimage (2010) 1.82
Retrospective motion correction protocol for high-resolution anatomical MRI. Hum Brain Mapp (2006) 1.80
Multi-site genetic analysis of diffusion images and voxelwise heritability analysis: a pilot project of the ENIGMA-DTI working group. Neuroimage (2013) 1.78
Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull (2006) 1.75
Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry (2004) 1.75
Retracted Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice. Circ Res (2008) 1.74
Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant (2004) 1.73
Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure. J Am Coll Cardiol (2007) 1.73
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. J Clin Psychiatry (2007) 1.73
Polyetheretherketone as a biomaterial for spinal applications. Biomaterials (2005) 1.73
The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr Bull (2007) 1.72
Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J Am Soc Nephrol (2006) 1.71
Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant (2005) 1.71
Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev (2012) 1.68
Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res Ther (2013) 1.67
Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients. J Clin Rheumatol (2009) 1.64
Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol (2003) 1.63
A metagenomic study of diet-dependent interaction between gut microbiota and host in infants reveals differences in immune response. Genome Biol (2012) 1.62
Global prefrontal and fronto-amygdala dysconnectivity in bipolar I disorder with psychosis history. Biol Psychiatry (2012) 1.62
On the genetic architecture of cortical folding and brain volume in primates. Neuroimage (2010) 1.62
Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. Nephrol Dial Transplant (2012) 1.59
The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects. Schizophr Res (2006) 1.57
Dorsolateral prefrontal cortex activity during maintenance and manipulation of information in working memory in patients with schizophrenia. Arch Gen Psychiatry (2005) 1.57
Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. J Clin Psychiatry (2003) 1.56
Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett (2011) 1.55
Prefrontal activation deficits during episodic memory in schizophrenia. Am J Psychiatry (2009) 1.53
Subclinical left ventricular dysfunction revealed by circumferential 2D strain imaging in patients with coronary artery disease and fragmented QRS complex. Heart Rhythm (2012) 1.52
Association of clinical symptoms and neurocognitive performance in bipolar disorder: a longitudinal study. Bipolar Disord (2011) 1.50
The reliability and validity of the Test of Adaptive Behavior in Schizophrenia (TABS). Psychiatry Res (2007) 1.45
Relationship between ventricular dyssynchrony and T-wave alternans in patients with coronary artery disease. Pacing Clin Electrophysiol (2011) 1.43
Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells. J Biol Chem (2010) 1.42
Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol (2004) 1.41
The functional connectivity of the human caudate: an application of meta-analytic connectivity modeling with behavioral filtering. Neuroimage (2011) 1.41
RPLC-ion-trap-FTMS method for lipid profiling of plasma: method validation and application to p53 mutant mouse model. J Proteome Res (2008) 1.40
Relationship of sRANKL level and vascular calcification score to cardiovascular events in maintenance hemodialysis patients. Blood Purif (2009) 1.39
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? Schizophr Bull (2008) 1.38
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry (2004) 1.35
Genetics of the connectome. Neuroimage (2013) 1.33
Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant (2007) 1.32
Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes (2010) 1.32
Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study. Biol Psychiatry (2013) 1.31
Mapping cortical thickness in children with 22q11.2 deletions. Cereb Cortex (2006) 1.30
Assembly of 500,000 inter-specific catfish expressed sequence tags and large scale gene-associated marker development for whole genome association studies. Genome Biol (2010) 1.29
Measuring and comparing brain cortical surface area and other areal quantities. Neuroimage (2012) 1.27
Preparation, facile deprotonation, and rapid H/D exchange of the mu-hydride diiron model complexes of the [FeFe]-hydrogenase containing a pendant amine in a chelating diphosphine ligand. Inorg Chem (2009) 1.27
Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology (2007) 1.27
Gut microbial gene expression in mother-fed and formula-fed piglets. PLoS One (2010) 1.27
Second generation intramedullary nailing of subtrochanteric femur fractures: a biomechanical study of fracture site motion. J Orthop Trauma (2002) 1.27
Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells. Am J Physiol Renal Physiol (2012) 1.26